✦ LIBER ✦

343 POSTER Phase I dose escalation study of the aurora kinase inhibitor PHA-739358 administered as a 24 hours infusion in a 14-day cycle in patients with advanced/metastatic solid tumor

✍ Scribed by H.A. Burris; G. Hudes; S. Jones; J. Cheng; D. Spigel; M. Mariani; H. Macdonald; M. Rocchetti; B. Laffranchi; R.B. Cohen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

27 ORAL Phase I dose escalation study of

✍ M. De Jonge; N. Steeghs; J. Verweij; J.W.R. Nortier; F. Eskens; J. Ouwerkerk; C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

282 POSTER Preliminary results of a Phas

✍ P. Schöffski; H. Dumez; S.F. Jones; C. Fowst; P. Gerletti; H. Xu; J. Jakubczak; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

411 POSTER A phase I, open-label, dose-e

✍ R. Salgia; A. Peterson; S. Eppler; W. Yu; B. Polite; D. Geary; E. Wesolowski; M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

414 POSTER A phase I, open-label, dose e

✍ M.S. Gordon; L.S. Rosen; F. Robert; D.S. Mendelson; D. Kleinzweig; B.J. Adams; C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB